In patients ≥ 16 years, substitution monotherapy for focal-onset or focal-to-bilateral tonic-clonic seizures after a concomitantly used enzyme-inducing antiseizure drug (eg, carbamazepine, phenytoin, phenobarbital) or valproate is stopped.